Downregulation of miR-217 correlates with resistance of ph+leukemia cells to ABL tyrosine kinase inhibitors
Author:
Affiliation:
1. Department of Hematology and Respiratory Medicine; Kochi Medical School; Kochi University; Nankoku Japan
2. The Facility for Animal Research; Kochi Medical School; Kochi University; Nankoku Japan
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12339/fullpdf
Reference27 articles.
1. Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL;Kantarjian;N Engl J Med,2006
2. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial;Kantarjian;Blood,2007
3. Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase following imatinib resistance or intolerance: 24-month follow-up results;Kantarjian;Blood,2011
4. Dasatinib overcomes imatinib and nilotinib failure in Philadelphia chromosome positive chronic myeloid leukemia with different mechanisms of resistance;Cannella;Leuk Lymphoma,2009
5. Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy;Giles;Leukemia,2010
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In the Pipeline: Emerging Therapy for CML;Pathogenesis and Treatment of Leukemia;2023
2. Construction of Lentiviral Vector for miR-217 Overexpression and Knockdown and Its Effect on CML;Molecular Biotechnology;2022-12-10
3. The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance;Life Sciences;2022-05
4. miR‑217‑5p suppresses epithelial‑mesenchymal transition and the NF‑κB signaling pathway in breast cancer via targeting of metadherin;Oncology Letters;2022-03-23
5. Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects;Expert Review of Hematology;2021-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3